Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder

Clinical trial NCT00227305 · COMPLETED

Trial details

NCT number: NCT00227305
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenia Bipolar I Disorder

Start date: 2004-08-01
Primary completion: 2007-12-01
Enrollment: 381

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.